Logos Global Management »

Newamsterdam Pharma Co Nv shares owned by Logos Global Management

Quarter-by-quarter ownership of Newamsterdam Pharma Co Nv (NAMS) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Newamsterdam Pharma Co Nv

Tip: Access up to 7 years of quarterly data

All positions including Newamsterdam Pharma Co Nv held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Newamsterdam Pharma Co Nv by Logos Global Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $16M 450k 35.08

More positions owned by Logos Global Management

Revolution Medicines Call Option (RVMD)
Ideaya Biosciences (IDYA)
Praxis Precision Medicines I Com New (PRAX)
Olema Pharmaceuticals (OLMA)
Cidara Therapeutics Com New (CDTX)
Abivax Sa Sponsored Ads (ABVX)
Erasca (ERAS)
Ocular Therapeutix (OCUL)
Structure Therapeutics Sponsored Ads (GPCR)
Disc Medicine (IRON)
Maze Therapeatics (MAZE)
Tango Therapeutics (TNGX)
Avidity Biosciences Ord (RNA)
Biogen Idec (BIIB)
Immunovant (IMVT)

View all positions for Logos Global Management

Top funds holding Newamsterdam Pharma Co Nv

Frazier Life Sciences Management
RA Capital Management
Capital World Investors
Fcpm Iii Services B.v.
Bain Capital Life Sciences Investors
FMR
Viking Global Investors
Deerfield Management Company
Wellington Management Company
Jennison Associates
Duquesne Family Office
Medicxi Ventures Management
Polar Capital Holdings
Adage Capital Partners GP
Alliancebernstein

View all funds holding Newamsterdam Pharma Co Nv